Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict.
When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud.
Gynecomastia may be a risk to boys and young men, causing growth of breasts that may require a partial or full mastectomy (surgical removal). The antipsychotic drug Risperdal (risperidone) has been linked to serious and potentially permanent side effects or death. One of the class of atypical antipsychotic drugs, Risperdal was originally approved for use in adults with schizophrenia and, later, for treatment of acute mania or mixed episodes associated with bipolar disorder in adults. Risperdal is manufactured by Janssen, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. The generic version, risperidone, is made by other manufacturers.
While anyone taking Risperdal may be at risk for harm, children and the elderly are at a significantly higher risk. Some children have experienced the significant, dangerous and potentially permanent side effects listed above. Children are especially at risk for additional side effects including severe weight gain, extreme rapid onset of diabetes and other blood disorders, and more pronounced movement disorders including tardive dyskinesia.
Sheller, P.C. lawyers are representing hundreds of boys and young men in ongoing trials in Philadelphia. If you or your son believe you may have suffered gynecomastia or elevated prolactin prior to 2008, we can help you understand your legal rights. Call 800-883-2299 or fill in the inquiry form on this page.
See Risperdal videos in our video library, including this:
Sheller, P.C. has also filed a citizen’s petition to the FDA, saying the approval of Risperdal for use in children should be revoked. Although the initial petition has been denied, Sheller has appealed.
Though approved for adults, until recently the use of Risperdal in children was not approved by the FDA and only approved now for very limited use in pediatric patients.
If doctors believe a drug can be an effective treatment for a patient’s condition, they can prescribe the drug “off-label,” meaning they may indicate the use in a population not approved by the FDA. In the last few years, Risperdal has consistently been prescribed “off-label” for children to treat autism, irritability, aggression and other behavior disorders including Attention Deficit Disorder/Hyperactivity Disorder (ADHD). Risperdal has also been prescribed to treat irritability, aggression and other behavior disorders in the elderly.
If you, your child or someone you know has experienced and/or has been diagnosed with gynecomastia or elevated prolactin while taking Risperdal or any other antipsychotic medication such as Invega, Geodon, Seroquel or Zyprexa, contact us by calling 800-883-2299 or filling out the inquiry form on this page to learn your rights and protect your health or the health of your child.
Johnson & Johnson Reaches Agreement with U.S. on Risperdal Criminal Charge Bloomberg News, August 10, 2011
Sheller, P.C.
1515 Market Street, Suite 1100
Philadelphia, PA 19102
Phone: 215-790-7300
info@sheller.com
